Alan B. Lancz & Associates, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Alan B. Lancz & Associates, Inc.
- $108 Million
- Q3 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 5,400 shares of AMPH stock, worth $273,186. This represents 0.24% of its overall portfolio holdings.
Number of Shares
5,400
Previous 5,400
-0.0%
Holding current value
$273,186
Previous $216,000
21.3%
% of portfolio
0.24%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
281Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$301 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$135 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$108 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$98.4 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$82.1 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.48B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...